Streetbeat News

Price Targets

IART

Truist Securities analyst Richard Newitter maintains a 'Hold' rating on Integra Lifesciences (NASDAQ:IART) and raises the price target from $44 to $48.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:48 pm

GMED

Truist Securities analyst Richard Newitter maintains a 'Hold' rating on Globus Medical (NYSE:GMED) and raises the price target from $64 to $68.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:47 pm

INTU

Unusual options activity has been observed for Intuit (NASDAQ:INTU), with a large position indicating a bullish stance. The sentiment among these big-money traders is split 50% bullish and 50% bearish. The options trades suggest a target price range of $460.0 to $500.0 for Intuit. Keybanc has maintained their Overweight rating on Intuit with a price target of $525, while Exane BNP Paribas upgraded its action to Neutral with a price target of $532.

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 1:46 pm

GM

Mizuho analyst Vijay Rakesh has maintained a Neutral rating on General Motors (NYSE:GM) and raised the price target from $37 to $40.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:46 pm

EW

Truist Securities analyst Richard Newitter maintains a 'Buy' rating on Edwards Lifesciences (NYSE:EW) and raises the price target from $101 to $105.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:45 pm

MSFT

Mizuho analyst Gregg Moskowitz maintains a Buy rating on Microsoft (NASDAQ:MSFT) and raises the price target from $390 to $420.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 1:40 pm

MSFT

JP Morgan analyst Mark Murphy has maintained an 'Overweight' rating on Microsoft (NASDAQ:MSFT) and raised the price target from $350 to $385.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 1:39 pm

BSX

Truist Securities analyst Richard Newitter maintains a 'Buy' rating on Boston Scientific (NYSE:BSX) and raises the price target from $60 to $61.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:36 pm

EPD

Mizuho analyst Gabriel Moreen maintains a Buy rating on Enterprise Prods Partners (NYSE:EPD) and raises the price target from $32 to $33.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2023 | 1:35 pm

AIR

Truist Securities analyst Michael Ciarmoli maintains a 'Buy' rating on AAR (NYSE:AIR) and raises the price target from $60 to $68.

Portfolio Pulse from richadhand@benzinga.com

July 19, 2023 | 1:34 pm